CatalystBio

CatalystBio is a privately held, service-oriented consultancy firm that acts as a strategic and operational partner for biotechnology companies. Its business model is centered on providing integrated, phase-appropriate expertise to help clients navigate complex development pathways, reach critical milestones, and enhance value. With a leadership team of seasoned biotech executives and former regulators, the firm offers deep functional knowledge in key development areas but does not own a proprietary technology platform or therapeutic pipeline of its own. Its success is tied to the broader biotech funding and outsourcing environment.

Integrated service model providing end-to-end biotech product development advisory and fractional leadership, leveraging collective expertise in regulatory, CMC, quality, preclinical, clinical, and project management.

Competes with large global management consultancies (e.g., McKinsey), specialized life sciences consulting boutiques, and a vast pool of independent consultants and fractional executives. Differentiation is based on integrated, hands-on execution and deep regulatory/operational expertise from its founder-led team.